Sodium-Glucose Transporters: A New Class of Diabetes Medications episode artwork

EPISODE · Sep 2, 2009 · 14 MIN

Sodium-Glucose Transporters: A New Class of Diabetes Medications

from Diabetes Discourse

Host: Steven Edelman, MD Guest: Vivian Fonseca, MD, FRCP SGLT2 is responsible for glucose re-absorption in the kidney and decreasing SGLT2 function promotes glucose excretion to help reduce blood sugar levels, making it an attractive area for the treatment of diabetes. Join host Dr. Steven Edelman and his guest, professor of medicine at Tulane University, Dr. Vivian Fonseca, as they discuss the new class of medications being investigated for the treatment of type-2 diabetes.

Episode metadata supplied by the publisher feed · Published Sep 2, 2009

Embed this episode

NOW PLAYING

Sodium-Glucose Transporters: A New Class of Diabetes Medications

0:00 14:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Diabetes Discourse?

This episode is 14 minutes long.

When was this Diabetes Discourse episode published?

This episode was published on September 2, 2009.

Can I download this Diabetes Discourse episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!